Cargando…

Impact of Sacubitril/Valsartan on Circulating microRNA in Patients with Heart Failure

Sacubitril/Valsartan, used for the treatment of heart failure (HF), is a combination of two drugs, an angiotensin receptor inhibitor, and a neprilysin inhibitor, which activates vasoactive peptides. Even though its beneficial effects on cardiac functions have been demonstrated, the mechanisms underp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brioschi, Maura, D’Alessandra, Yuri, Mapelli, Massimo, Mattavelli, Irene, Salvioni, Elisabetta, Eligini, Sonia, Mallia, Alice, Ricci, Veronica, Gianazza, Erica, Ghilardi, Stefania, Agostoni, Piergiuseppe, Banfi, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136141/ https://www.ncbi.nlm.nih.gov/pubmed/37189655 http://dx.doi.org/10.3390/biomedicines11041037

Ejemplares similares

Immature Circulating SP-B, Bound to HDL, Represents an Early Sign of Smoke-Induced Pathophysiological Alterations
por: Banfi, Cristina, et al.
Publicado: (2021)

Looking into the Kinetics of NT-proBNP and sST2 Changes in Patients with Heart Failure Treated with Sacubitril/Valsartan: A Hint to Different Therapeutic Pathways
por: Mapelli, Massimo, et al.
Publicado: (2023)

Prenylcysteine Oxidase 1 Is a Key Regulator of Adipogenesis
por: Banfi, Cristina, et al.
Publicado: (2023)

Cardiac Reverse Remodelling by 2D and 3D Echocardiography in Heart Failure Patients Treated with Sacubitril/Valsartan
por: Mantegazza, Valentina, et al.
Publicado: (2021)

Multiplexed MRM-Based Proteomics Identified Multiple Biomarkers of Disease Severity in Human Heart Failure
por: Brioschi, Maura, et al.
Publicado: (2021)

Macrophage Phenotyping in Atherosclerosis by Proteomics
por: Eligini, Sonia, et al.
Publicado: (2023)

Impact of Sacubitril/Valsartan on surfactant binding proteins, central sleep apneas, lung function tests and heart failure biomarkers: Hemodynamic or pleiotropism?
por: Mapelli, Massimo, et al.
Publicado: (2022)

Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration
por: Mapelli, Massimo, et al.
Publicado: (2023)

S-Thiolation Targets Albumin in Heart Failure
por: Brioschi, Maura, et al.
Publicado: (2020)

Platelets in Healthy and Disease States: From Biomarkers Discovery to Drug Targets Identification by Proteomics
por: Gianazza, Erica, et al.
Publicado: (2020)

N-Acetylcysteine Regenerates In Vivo Mercaptoalbumin
por: Altomare, Alessandra Anna, et al.
Publicado: (2022)

Proteomics of Extracellular Vesicles: Update on Their Composition, Biological Roles and Potential Use as Diagnostic Tools in Atherosclerotic Cardiovascular Diseases
por: Mallia, Alice, et al.
Publicado: (2020)

Dramatic disease regression in a case of HFrEF with end‐stage renal failure treated with sacubitril/valsartan and SGLT2i
por: Mapelli, Massimo, et al.
Publicado: (2023)

Sacubitril/Valsartan Conundrum
por: Somberg, John
Publicado: (2021)

Lipoxidation in cardiovascular diseases
por: Gianazza, Erica, et al.
Publicado: (2019)

Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges
por: Gianazza, Erica, et al.
Publicado: (2023)

Case Report: Acute Heart Failure Induced by the Combination of Takayasu's, Takotsubo and Coronary Vasospasm in an Elementary School Teacher–A Reaction to Return-to-Work Stress After COVID-19?
por: Pires, Inês, et al.
Publicado: (2022)

“Under the Bridge”: Looking for Ischemia in a Patient with Intramyocardial Coronary Artery Course—The Role of the Cardiopulmonary Exercise Test
por: Mapelli, Massimo, et al.
Publicado: (2023)

Implication of low dose sacubitril/valsartan
por: Imamura, Teruhiko
Publicado: (2021)

Eligibility and Usage of Sacubitril/Valsartan in Korea
por: Kim, Jin-Jin, et al.
Publicado: (2019)

Editorial: Exercise and heart failure
por: Salvioni, Elisabetta, et al.
Publicado: (2022)

Renin profiling predicts neurohormonal response to sacubitril/valsartan
por: Vergaro, Giuseppe, et al.
Publicado: (2020)

A Breathtaking Lift: Sex and Body Mass Index Differences in Cardiopulmonary Response in a Large Cohort of Unselected Subjects with Acute Exposure to High Altitude
por: Vignati, Carlo, et al.
Publicado: (2021)

Cardiopulmonary exercise testing and heart failure: a tale born from oxygen uptake
por: Mapelli, Massimo, et al.
Publicado: (2023)

Insights into implementation of sacubitril/valsartan into clinical practice
por: Martens, Pieter, et al.
Publicado: (2018)

Sacubitril–valsartan in heart failure and multimorbidity patients
por: Rodil Fraile, Raquel, et al.
Publicado: (2018)

Re: Implication of low‐dose sacubitril/valsartan
por: Pandey, Amitabh C., et al.
Publicado: (2021)

Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
por: Mustafa, Nor Hidayah, et al.
Publicado: (2022)

Effects of Sacubitril/Valsartan on the Renal Resistance Index
por: Gioia, Margherita Ilaria, et al.
Publicado: (2022)

Surfactant-Derived Proteins as Markers of Alveolar Membrane Damage in Heart Failure
por: Gargiulo, Paola, et al.
Publicado: (2014)

The MECKI score initiative: Development and state of the art
por: Salvioni, Elisabetta, et al.
Publicado: (2020)

Redox Proteomics Identification of Oxidatively Modified Myocardial Proteins in Human Heart Failure: Implications for Protein Function
por: Brioschi, Maura, et al.
Publicado: (2012)

Effect of sacubitril/valsartan or valsartan on ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension
por: Chen, Jianshu, et al.
Publicado: (2023)

Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment
por: Anderson, Sarah L, et al.
Publicado: (2018)

The Diuretic Effect of Sacubitril/Valsartan Might Be Clinically Relevant
por: Beck-da-Silva, Luís, et al.
Publicado: (2019)

Practical guidance on the use of sacubitril/valsartan for heart failure
por: Sauer, Andrew J., et al.
Publicado: (2018)

Sacubitril/valsartan increases postprandial gastrin and cholecystokinin in plasma
por: Andersen, Ulrik Ø, et al.
Publicado: (2020)

Effectiveness of sacubitril–valsartan in cancer patients with heart failure
por: Martín‐Garcia, Ana, et al.
Publicado: (2020)

Sacubitril/valsartan in the treatment of systemic right ventricular failure
por: Zandstra, Tjitske E, et al.
Publicado: (2021)

Haemodynamic effects of sacubitril/valsartan in advanced heart failure
por: Gentile, Piero, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vsfk0vrdcfbqgc1fh1s1spcc9p